4BIO CAPITAL
4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs. 4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech - biologics, gene and cell therapy and bioinformatics.
4BIO CAPITAL
Industry:
Genetics
Founded:
2014-12-01
Status:
Active
Contact:
+44 (0) 203 427 5500
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Apollo Health Ventures
Apollo Health Ventures is a venture capital firm investing in seed and early stage biotechnology companies.
Batavia Biosciences
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Code Biotherapeutics | 4BIO Capital investment in Series A - Code Biotherapeutics | 75 M USD |
| 2022-06-06 | LUCA Science | 4BIO Capital investment in Series B - LUCA Science | 3.86 B JPY |
| 2022-01-04 | Ray Therapeutics | 4BIO Capital investment in Seed Round - Ray Therapeutics | 6 M USD |
| 2021-04-20 | Code Biotherapeutics | 4BIO Capital investment in Seed Round - Code Biotherapeutics | 10 M USD |
| 2021-03-01 | Carisma Therapeutics | 4BIO Capital investment in Series B - Carisma Therapeutics | 12 M USD |
| 2020-10-22 | Araris Biotech | 4BIO Capital investment in Seed Round - Araris Biotech | 15.2 M CHF |
| 2020-10-21 | SparingVision | 4BIO Capital investment in Venture Round - SparingVision | 44.5 M EUR |
| 2020-03-25 | Redpin Therapeutics | 4BIO Capital investment in Series A - Redpin Therapeutics | 15.5 M USD |
| 2018-01-01 | Autolus | 4BIO Capital investment in Post-IPO Equity - Autolus | N/A |
| 2017-12-20 | Orchard Therapeutics | 4BIO Capital investment in Series B - Orchard Therapeutics | 110 M USD |